GGHC
RNLX

Gilder Gagnon Howe & Co’s Renalytix plc American Depositary Shares RNLX Stock Holding History

Gilder Gagnon Howe & Co’s Portfolio RNLX Stock Details RNLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-761,108
Closed -$655K – 286
2024
Q1 		$655K Sell
761,108
-118,343
-13% -$81K 0.01% 230
2023
Q4 		$343K Sell
879,451
-132,433
-13% -$106K ﹤0.01% 232
2023
Q3 		$1.62M Sell
1,011,884
-15,862
-2% -$43.8K 0.02% 188
2023
Q2 		$3M Buy
1,027,746
+46,810
+5% +$106K 0.04% 178
2023
Q1 		$2.37M Sell
980,936
-28,147
-3% -$78.1K 0.04% 166
2022
Q4 		$1.89M Sell
1,009,083
-176,780
-15% -$276K 0.04% 176
2022
Q3 		$1.52M Sell
1,185,863
-372,421
-24% -$811K 0.03% 184
2022
Q2 		$3.82M Sell
1,558,284
-1,264,425
-45% -$6.01M 0.07% 148
2022
Q1 		$19.5M Sell
2,822,709
-255,017
-8% -$2.7M 0.18% 112
2021
Q4 		$48.9M Sell
3,077,726
-148,686
-5% -$2.98M 0.28% 87
2021
Q3 		$64.7M Sell
3,226,412
-40,606
-1% -$1.05M 0.34% 74
2021
Q2 		$101M Buy
3,267,018
+245,701
+8% +$7.36M 0.49% 59
2021
Q1 		$77.5M Buy
3,021,317
+470,577
+18% +$11.8M 0.42% 71
2020
Q4 		$40.8M Buy
2,550,740
+51,208
+2% +$632K 0.2% 115
2020
Q3 		$30.5M Buy
+2,499,532
New +$36.1M 0.19% 115

Other funds holding RNLX

PA
Pinnacle Associates New York $9.16B AUM 63.5% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $120B AUM 27.84% 1-Year Est. Return
LCS
Levin Capital Strategies New York $1.49B AUM 30.44% 1-Year Est. Return
TC
Tejara Capital London, United Kingdom $243M AUM 9.84% 1-Year Est. Return
Corient Private Wealth
Corient Private Wealth Miami, Florida $72.2B AUM 27.85% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
CF
Cantor Fitzgerald New York $9.31B AUM 73.66% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
TCM
Traynor Capital Management Malvern, Pennsylvania $2.18B AUM 62.36% 1-Year Est. Return
NSIM
North Star Investment Management Chicago, Illinois $1.84B AUM 28.81% 1-Year Est. Return

Gilder Gagnon Howe & Co's RNLX Position: Q2 2024 in Review

Gilder Gagnon Howe & Co sold out of Renalytix plc American Depositary Shares (RNLX) in Q2 2024, closing a stake of 761,108 shares — an estimated $655K sold.

Gilder Gagnon Howe & Co first reported a position in RNLX in Q3 2020 and held it in 15 quarters. The position peaked at $101M in Q2 2021. 26 funds tracked by Wall St. Rank hold RNLX as of Q2 2024.

  • Gilder Gagnon Howe & Co reported no remaining Renalytix plc American Depositary Shares position as of Q2 2024 after selling out during the quarter.
  • Gilder Gagnon Howe & Co sold 761,108 Renalytix plc American Depositary Shares shares in Q2 2024, an estimated $655K.
  • Gilder Gagnon Howe & Co first reported a position in Renalytix plc American Depositary Shares in Q3 2020 and held it in 15 quarters.
  • Gilder Gagnon Howe & Co's Renalytix plc American Depositary Shares position peaked at $101M in Q2 2021.
  • 26 funds tracked by Wall St. Rank held Renalytix plc American Depositary Shares as of Q2 2024.

Based on Gilder Gagnon Howe & Co's 13F filing for Q2 2024, filed 14 Aug 2024.